Subsequent immunohistochemical (IHC) analysis showed PSMA to be highly expressed in the epithelial cells of the prostate with an intense over-expression in prostate cancer, where its increased expression was shown to correlate with advanced disease stage and the presence of distant metastases [2,4,5]. The gene discussed is FOLH1; the disease is prostate carcinoma.